₅S Langouët

Summary for 2001 [at-glance overview of S Langouët work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author S Langouët. According to available data, in 2001 S Langouët published at least 5 articles. This work was completed in collaboration with several authors including Guillouzo, A and Guengerich, F P. Several other authors have collaborated with S Langouët as well. There is no information about the funding or the grants awarded to support this work.

S Langouët has rank 8 when compared to all other authors using the keyword Quinoxalines. Analysis of the article abstracts and the titles suggests that S Langouët professional interests are focused around "5-f quinoxaline human", "2-amino-3 8-dimethylimidazo 5-f" and "8-dimethylimidazo 5-f quinoxaline". These might also be referred to as "multidrug resistance", "2-amino-3 8-dimethylimidazo" or "quinoxaline human". Statistical analysis shows that S Langouët's writing is likely to contains terms "cells", "human", "5-f", "quinoxaline", "liver" and "resistance".

Unfortunately, there is not enough information to establish S Langouët affiliation. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for S Langouët]

Do you know S Langouët who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to S Langouët]

₁₅Langouët, Sophie

Year 2001 Charts [S Langouët frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of S Langouët publication and funding history for the range of years]

Emails (2) [email addresses extracted from S Langouët affiliations]

hidden to prevent spam, click here to reveal

S Langouët Coauthors (9) [all coauthors with the number of joint publications]

4

3

3

2

1

1

1

1

1

Other [context-specific ads]

Affiliations (5) [condensed summary of the S Langouët affiliations, the leading number and the color conveys importance]

₁Nestlé Research Center, Nestec Ltd., Vers-chez-les-Blanc, 1000 Lausanne 26, Switzerland.
₁INSERM U456, Faculté de Pharmacie, Université de Rennes I, 35043 Rennes, France.
₁INSERM U456, Detoxication et Reparation Tissulaire, Faculté de Pharmacie, 2 Avenue du Pr L. Bernard, 35043 Rennes Cedex, France.
₁INSERM U456, Faculté de Pharmacie, Rennes, France.
₁INSERM U456, Détoxication et Réparation Tissulaire, Faculté des Sciences Pharmaceutiques et Biologiques, Université de Rennes I, France.

Key Opinion Leader In [S Langouët is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₈Quinoxalines | ₁₀Cytochrome P-450 CYP1A2 | ₃₃Mutagens | ₈₄Hepatocytes

Keywords (32) [keywords assigned to S Langouët articles by PubMed, the leading number and the color conveys importance]

₄Rats | ₄Hepatocytes | ₄Animals | ₄Humans | ₃Quinoxalines | ₃Cytochrome P-450 CYP1A2 | ₃Cells, Cultured | ₃Mutagens | ₂Tumor Cells, Cultured | ₂Theophylline | ₂Metabolic Detoxication, Drug | ₂DNA Adducts | ₂Microsomes, Liver | ₂Biotransformation | ₂Enzyme Inhibitors | ₁Benzopyrenes | ₁Species Specificity | ₁Vincristine | ₁Multidrug Resistance-Associated Proteins | ₁RNA, Messenger | ₁Recombinant Proteins | ₁Substrate Specificity | ₁Cisplatin | ₁Chromatography, High Pressure Liquid | ₁Carcinogens | ₁Molecular Structure | ₁Antineoplastic Agents | ₁P-Glycoprotein | ₁Methylcholanthrene | ₁Rats, Wistar | ₁P-Glycoproteins | ₁Drug Resistance, Multiple

S Langouët Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; S Langouët might be a good expert witness on these terms]

₁₂cells | ₈human | ₇5-f | ₇quinoxaline | ₇liver | ₆resistance | ₆p450 | ₆rat | ₅8-dimethylimidazo | ₅2-amino-3 | ₅multidrug | ₅metabolism | ₅1a2 | ₄differences | ₄f258 | ₄transporters | ₄pathway | ₄3mc | ₄meiqx | ₄pah | ₃hepatocytes | ₃major | ₃activity | ₃expression | ₃efflux | ₂acid | ₂p-glycoprotein | ₂mutagen | ₂risk | ₂considered | ₂affect | ₂mrp2
₅multidrug resistance | ₅2-amino-3 8-dimethylimidazo | ₅quinoxaline human | ₅8-dimethylimidazo 5-f | ₅5-f quinoxaline | ₅p450 1a2 | ₅rat liver | ₄resistance transporters | ₄liver cells | ₃human hepatocytes | ₃3mc cells | ₃human rat | ₃expression multidrug | ₃f258 3mc | ₂detoxification pathway | ₂considered assessing | ₂assessing human | ₂affect biological | ₂unaltered expression | ₂polycyclic aromatic | ₂transporters polycyclic | ₂1a2 quinoxaline | ₂n-oxidation 2-amino-3 | ₂health risk | ₂must considered | ₂5-f quinoxaline-8-carboxylic | ₂liver microsomes | ₂catalyzed cytochrome | ₂human health | ₂cytochrome p450 | ₂regioselective differences | ₂major detoxification
₅5-f quinoxaline human | ₅2-amino-3 8-dimethylimidazo 5-f | ₅8-dimethylimidazo 5-f quinoxaline | ₄multidrug resistance transporters | ₃quinoxaline human hepatocytes | ₃expression multidrug resistance | ₃f258 3mc cells | ₂cytochromes p450 1a2 | ₂unaltered expression multidrug | ₂rat liver microsomes | ₂aromatic hydrocarbon-resistant rat | ₂major detoxification pathway | ₂n-oxidation 2-amino-3 8-dimethylimidazo | ₂hydrocarbon-resistant rat liver | ₂quinoxaline human rat | ₂hepatocytes 2-amino-3-methylimidazo 5-f | ₂affect biological activity | ₂rat liver cells | ₂p450 1a2 quinoxaline | ₂regioselective differences n-oxidation | ₂must considered assessing | ₂polycyclic aromatic hydrocarbon-resistant | ₂quinoxaline-8-carboxylic acid major | ₂metabolism 2-amino-3 8-dimethylimidazo | ₂detoxification pathway catalyzed | ₂pathway catalyzed cytochrome | ₂transporters polycyclic aromatic | ₂considered assessing human | ₂differences n-oxidation 2-amino-3 | ₂acid major detoxification | ₂resistance transporters polycyclic | ₂human hepatocytes 2-amino-3-methylimidazo

Reader's Comments (0) [comments posted by readers of S Langouët profile]